Vincent Luong

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

ST läkare, Medicinsk Enhet Hematologi, Karolinska Universitetssjukhuset
Doktorand, Myeloma Group, MedH/HERM, Karolinska Institutet

Artiklar

Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754
Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(4):546-554
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups
Afram G; Susek KH; Uttervall K; Wersall JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H

Alla övriga publikationer

Conference publication: BLOOD. 2024;144(Supplement 1):3320
Outcomes of Relapsed and Refractory Multiple Myeloma with the Evolving Standard of Care
Luong V; Kashif M; Uttervall K; Bohlin A; Cetrez N; Afram G; Nahi H; Lund J; Alici E
Conference publication: BLOOD. 2024;144(Supplement 1):3318
A Lightweight Risk Scoring System for Stratification of Newly Diagnosed Multiple Myeloma Patients
Riga G; Luong V; Uttervall K; Gahrton G; Nahi H; Lund J; Alici E; Kashif M
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2024;24:S269-S270
P-407 Real-World Outcomes in Patients With Relapsed-Refractory Multiple Myeloma (RRMM) With Prior Proteasome Inhibitor and Lenalidomide Exposure in Sweden
Luong V; Kashif M; Uttervall K; Bohlin A; Fernström AÖ; Qu Y; Lee S; Mendes J; Van Hoorenbeeck S; Franck EH; He J; Alici E; Lund J
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2024;24:S269-S270
Real-World Outcomes in Patients With Relapsed-Refractory Multiple Myeloma (RRMM) With Prior Proteasome Inhibitor and Lenalidomide Exposure in Sweden
Luong V; Kashif M; Uttervall K; Bohlin A; Fernstrom AO; Qu Y; Lee S; Mendes J; Van Hoorenbeeck S; Franck EH; He J; Alici E; Lund J
Meeting abstract: BLOOD. 2023;142:1960
A Novel Biosignature for Potential Stratification and Elucidation of Newly Diagnosed Multiple Myeloma Patients at-Risk
Kashif M; Zhou Y; Luong V; Uttervall K; Gahrton G; Nahi H; Alici E; Lund J
Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(2):224-225
Response to Caravita di Toritto and Rago
Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H; Afram G
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2022;22:S130
P-173: Prognostic utility of the evolving biomarkerbased progression model (e-model) for smoldering multiple myeloma (SMM) in a diverse population
Atrash S; Robinson M; Cassetta K; Varga C; Pineda-Roman M; Friend R; Paul B; Usmani S; Luong V; Voorhees P; Hareth N; Bhutani M
Conference publication: CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA. 2022;22:S130
Prognostic utility of the evolving biomarker-based progression model (e-model) for smoldering multiple myeloma (SMM) in a diverse population
Atrash S; Robinson M; Cassetta K; Varga C; Pineda-Roman M; Friend R; Paul B; Usmani S; Luong V; Voorhees P; Hareth N; Bhutani M
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(3):E63-E65
Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression
Gran C; Luong V; Bruchfeld JB; Liwing J; Afram G; Lund J; Usmani S; Alici E; Nahi H
Meeting abstract: BLOOD. 2016;128(22):563
Difference in Fibrin Clot Structure in Haemophilia A and Haemophilia B
Luong V; Soutari N; Berndtsson M; Holmstrom M; Antovic JP; Chaireti R

Anställningar

Doktorand | Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2023-2027

Examina och utbildning

Läkarexamen, Karolinska Institutet, 2017

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI